Exane Derivatives’s Viking Therapeutics VKTX Stock Holding History

Exane Derivatives’s Portfolio VKTX Stock Details VKTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$83.3K	Buy
2021 Q4	–	Sell
2021 Q3	$189K	Buy
2021 Q2	$141K	Sell
2021 Q1	$285K	Sell
2020 Q4	$289K	Buy
2020 Q3	$261K	Buy
2020 Q2	$316K	Sell
2020 Q1	$249K	Buy